Castle Biosciences Inc (CSTL): Cost of Revenue
$71.03M
Year ended 2025-12-31
$81.25M
Trailing 12 months to 2026-06-30
+30.4%
3-year compound annual growth
+49.0%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $71.03M | +18.0% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $60.20M | +33.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $44.98M | +40.5% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $32.01M | +102.3% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $15.82M | +63.4% | 2023-02-28, From 2021-01-01 |
| 2020-12-31 | $9.69M | +32.5% | 2022-02-28, From 2020-01-01 |
| 2019-12-31 | $7.31M | +38.0% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $5.30M | n/a | 2020-03-10, From 2018-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $71.03M | +18.0% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $191.80M | +8.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $96.65M | +34.9% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $349.01M | +20.4% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $53.87M | -6.8% |
| Exagen Inc. (XGN) | 2025-12-31 | $27.78M | +23.3% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $23.02M | +20.2% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $7.37B | +11.2% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $9.94B | +5.9% |
Compare CSTL, FLGT, BLLN, GH side by side · Screen every company in Services-Medical Laboratories ↗